News & Resources

Virtual KOL Engagement: Building a Successful Outreach Strategy

The global pandemic has caused seismic changes in the medical and pharma industry. In recent years, the industry has begun a gradual shift toward virtual connections; COVID accelerated these trends, canceling swaths of conferences and conventions. This shift is likely to become permanent in some regions. Attendees and hosts have discovered that virtual tools have many unique benefits.

Key opinion leaders (KOLs) may promote an ongoing shift away from in-person meetings; these individuals enjoy the freedom and flexibility that comes with virtual meetings. Digital platforms allow KOLs to fit meetings and outreach into their busy schedules. Medical and pharma companies must adapt or risk losing touch with their advisory team.

Now, more than ever, your company needs KOL insight. The global medical system faces many challenges in the 21st century – different mindsets, priorities, and policies are emerging. By anticipating coming changes, your company can position itself for success.

Read on to learn more about developing a virtual KOL outreach strategy.

KOLs offer valuable insight
KOL outreach can make or break your organization. These individuals offer on-the-ground insight into treatment patterns within the healthcare system; they understand patients’ priorities and providers’ concerns. KOLs can help your organization understand what drives clinical decision-making, which helps your company refine its strategic planning.

Their insights can also drive marketing and branding processes, as they identify pain points for patients and providers. Your organization can use their input to craft a successful marketing message; by offering persuasive, relevant information, you can build interest in a new treatment. KOL insights also help your organization introduce products at the right time.

Overcoming outreach hurdles
Unfortunately, connecting with KOLs can be a challenge. In the past, many companies simply attended conventions or conferences, but pamphlets and booths are no longer a viable strategy because most conferences have shifted online. KOLs are increasingly wary of in-person meetings, so most outreach now takes place digitally. As a result, companies need a sharp, responsive strategy for virtual communications.

Your strategy should center around providing value to KOLs; today’s KOLs aren’t willing to take time out of their busy day to listen to a tedious lecture. Often, they grapple with a jam-packed schedule and unprecedented job stress. The most desirable experts are sought-after by many companies. They can’t accept every invitation and they won’t invest in a meeting that offers little value.

As KOLs consider invitations, they may ask themselves, “What’s in it for me?” They know that medical and pharma companies rely on their expertise, but outreach should never be one-sided. Companies can offer reciprocal benefits to build deeper relationships. As you plan a virtual outreach strategy, consider the following tips:

Do your homework
KOLs gravitate toward experienced, well-informed organizations. They understand that your company has questions and needs expert input. Still, they expect that companies will have done some background research.

Make sure to review key meeting topics in advance, and arm yourself with useful insights and relevant statistics. This research process lets your company share information about your products or accomplishments. Ensure that you have access to clinical and research data that supports your points.

Choose the right platform
KOLs often have a tight schedule, and synchronous meetings can be bothersome. Flexible online platforms allow your contacts to join discussions on their own timetable. The best platforms offer a range of tools for rich discussions between members. They let attendees break into small groups and share multimedia presentations. Consider which tools offer the best alternatives to in-person meetings, then look for a platform that meets your needs.

Make the most of virtual tools
Once you’ve made a selection, familiarize your team with the platform. Ensure that team members know how to troubleshoot and use each tool; create a troubleshooting plan in advance. Look for platforms that offer integrated tech support, then select one team member as a main point of contact to streamline assisting clients or contacts who run into trouble.

Remember that virtual meetings are only one tool in your arsenal. After the meeting ends, plan for follow-up activities, which can include Q&A sessions, networking time, and more. These activities help deepen your connection with attendees; they keep the discussion flowing and offer added value.

Be selective with invitations
Your company needs to connect with KOLs who align with your priorities. You may gravitate toward individuals with recognizable names or a dazzling resume, but consider whether this particular person is a good fit. Outreach for the sake of outreach is a waste of everyone’s time. Create a detailed checklist and identify KOLs who can help your company reach its goals.

Look for individuals with expertise in your particular niche. Consider approaching KOLs who have led clinical trials or published in major journals. Providers who specialize in certain regions or demographics are another good resource.

You may find it helpful to look for several contacts, each one with a unique background; a diverse group can provide different perspectives and insights. Determine what kind of expertise you need, and then look for KOLs who fit the bill.

Offer unique opportunities
If your initial meeting goes well, your contact may want to deepen the connection. KOLs often seek out opportunities to engage in research projects, clinical trials, and advisory boards. They may also enjoy sponsorship opportunities or special networking events. Consider what your company can offer, then make plans for how to follow up with these offers after the meeting is over.

The bottom line
Virtual outreach can be challenging, but the right strategy can help your company stay connected to KOLs. Digital tools help you engage with KOLs and build relationships with qualified experts. Versatile platforms can allow for in-depth discussion and collaboration – these tools help mimic the conference environment and keep attendees engaged.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.